Cingulate Inc. Skyrocketed

Wed, Dec 27, 2023 at 11:31 PM

Cingulate Inc. (CING:NASDAQ) jumped higher at $3.99, representing a gain of 90.9%. On Wed, Dec 27, 2023, CING:NASDAQ hit a New 2-Week High of $3.99. The stock got featured on our News Catalysts scanner on Wed, Dec 06, 2023 at 10:21 AM in the 'MISCELLANEOUS' category. From Thu, Dec 14, 2023, the stock recorded 37.50% Up Days and 44.44% Green Days

The stock spiked on Wed, Dec 27, 2023 at $5.1 with a volume of 50M+.

About Cingulate Inc. (CING:NASDAQ)

Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical...

Top 10 Gainers:

Oncorus Inc. (ONCR:NASDAQ), 669.23%
Esports Technologies Inc. (EBET:NASDAQ), 244.43%
RiskOn International Inc Com Par $0.001 (ROI:NASDAQ), 205.4%
Republic First Bancorp, Inc. (FRBK:NASDAQ), 110.74%
Cingulate Inc. (CING:NASDAQ), 90.91%
Cytokinetics, Incorporated (CYTK:NASDAQ), 82.54%
Earlyworks Co. Ltd. (ELWS:NASDAQ), 69.31%
Erayak Power Solution Group Inc. (RAYA:NASDAQ), 50.73%
First Wave BioPharma Inc. (FWBI:NASDAQ), 50.27%
Vince Holding Corp. (VNCE:NYSE), 48.68%